Business Wire

Velodyne Lidar’s Groundbreaking Sensors Power Kaarta Mobile Mapping

Share

Velodyne Lidar, Inc. today announced Kaarta has included Velodyne’s smart, powerful lidar technology in Kaarta’s new Stencil 2-32 ground surface mapping solution. Equipped with Velodyne lidar, Stencil 2-32 accurately scans ground level surfaces, mapping items such as curbs, manholes, signs, poles, and other features at a fraction of the cost of traditional mobile mapping systems. The Stencil platform helps enable city planning for infrastructure improvements as well as parking and traffic management.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190716005210/en/

Kaarta’s new Stencil 2-32 ground surface mapping solution includes Velodyne’s smart, powerful lidar technology. (Photo: Business Wire)

Kaarta’s new Stencil 2-32 ground surface mapping solution includes Velodyne’s smart, powerful lidar technology. (Photo: Business Wire)

The 3D data generated by Stencil 2-32 can be utilized for a range of applications including BIM modeling, geospatial data analytics, and cataloging tools. For example, Allvision uses Stencil 2-32 along with data from an autonomous vehicle developer to conduct curb occupancy analysis in Pittsburgh’s Strip District, an area known for high on-street parking demands. Called Allvision Parkview, the solution allows city planners to monitor parking behavior to improve transportation planning and curb management.

“The addition of Stencil 2-32 to Kaarta’s product line further extends the range of mapping applications for mobile lidar scanning,” said Kevin Dowling, Ph.D., CEO, Kaarta. “The low noise, long range, and field of view of Velodyne’s compact lidar sensors allow us to create systems with immense versatility, accuracy, and speed – from capture to answer.”

Stencil integrates 3D mapping and real-time position estimation to create capabilities not possible with fixed-base scanning systems. Stencil 2-32 incorporates the Velodyne HDL-32E lidar sensor, which provides a range of 100 meters and a data rate of 720,000 points per second. Kaarta leverages advanced robotics technology that combines input from multiple sensors – lidar, visual odometry, and inertial measurement unit (IMU) – and processes that data in real time. For some applications, the data can be enhanced with Global Navigation Satellite System (GNSS) positioning and wheel odometry sensors.

“Velodyne lidar and Kaarta’s advanced 3D mapping and localization algorithms are a phenomenal combination, creating a portable system for fast and easy detailed surface mapping,” said Aaron Morris, Founder and CEO, Allvision. “The ability to rapidly gather accurate and up-to-date geospatial information has countless applications.”

Stencil 2-32 is the newest member of Kaarta’s Stencil product line which also includes Stencil 2-16, a versatile low-cost mobile mapping platform that uses the Velodyne Puck™ sensor. Its ease of use, breadth of applications, and streamlined workflow make the system well-suited for infrastructure inspectors, surveyors, engineers, architects, facilities planners, security personnel, and more.

“Kaarta and Allvision demonstrate how to tap the full potential of Velodyne’s rich computer perception data for an innovative solution to inventory, track, and monitor assets for accurate future planning and management,” said Mike Jellen, President and CCO, Velodyne Lidar.

About Velodyne Lidar
Velodyne provides smart, powerful lidar solutions for autonomy and driver assistance. Founded in 1983 and headquartered in San Jose, Calif., Velodyne is known worldwide for its portfolio of breakthrough lidar sensor technologies. In 2005, Velodyne’s Founder and CEO, David Hall, invented real-time surround view lidar systems, revolutionizing perception and autonomy for automotive, new mobility, mapping, robotics, and security. Velodyne’s high-performance product line includes a broad range of sensing solutions, including the cost-effective Puck™, the versatile Ultra Puck™, the autonomy-advancing Alpha Puck™, the ADAS-optimized Velarray™, and the groundbreaking software for driver assistance, Vella™.

About Kaarta
Kaarta is the innovator of real-time mobile 3D reality capture, mapping complex environments with unprecedented speed, fidelity and ease. Kaarta works without external signal infrastructure such as GPS or Wi-Fi. Kaarta’s patent-pending technology, rooted in advanced robotics, accurately transforms the real world into 3D digital twins, streamlining workflow, reducing time, lowering cost, and providing a new level of understanding of spaces for humans and autonomous machines alike. Now the spectrum of stakeholders across architecture, engineering, construction, and property owner/operators, facilities planners and managers, and mobile robotics developers can work from the same truth. Additional information is available at www.kaarta.com.

Contact information

Sean Dowdall
Landis Communications Inc. for Velodyne Lidar, Inc.
(415) 286-7121
velodyne@landispr.com

Kathy Pattison
Kaarta
(617) 515-6946
media@kaarta.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Velodyne Files Patent Infringement Complaint with ITC Against Hesai and RoboSense16.8.2019 12:00:00 CESTPress release

Velodyne Lidar, Inc. filed a patent infringement complaint with the U.S. International Trade Commission (ITC) against Hesai Photonics Technology Co., Ltd. and Suteng Innovation Technology Co., Ltd. (a.k.a. RoboSense) for violations of section 337 of the Tariff Act of 1930 which makes unfair methods of competition and importation of certain products into the United States unlawful. Earlier this week, Velodyne also filed patent infringement complaints against Hesai and RoboSense in the U.S. District Court for the Northern District of California. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190816005041/en/ Velodyne Lidar’s Alpha Puck™, Ultra Puck™ and Puck™ surround view sensors (left to right). (Photo: Business Wire) Velodyne is asking the ITC to investigate these lidar manufacturers for unlawfully importing and selling lidar sensors that infringe Velodyne’s patented lidar technology (U.S. Patent 7,969,558). Velodyne reques

Merz Announces Key Governance Changes16.8.2019 09:26:00 CESTPress release

Merz, a global leader in medical aesthetics and specialty neurology, announced today that Philip Burchard will be appointed Chairman of the company’s Shareholders Council. He will assume this role in addition to his current position as Chief Executive Officer of the Merz Healthcare Group. In his new position, Philip Burchard will succeed Andreas Krebs, who has decided to step down from his current roles as Chairman of the Shareholders Council and Supervisory Board of Merz in order to dedicate more time to his personal entrepreneurial and philanthropic activities. In addition, Dr. Christian Holzherr will be the new Chairman of the Merz Supervisory Board. All changes will be effective as of October 31, 2019. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190816005106/en/ Philip Burchard, CEO of Merz (Photo: Business Wire) Philip Burchard joined Merz as CEO in July 2012. Under his leadership, Merz has focused its strategy on ae

FINEOS lists on the Australian Securities Exchange16.8.2019 07:22:00 CESTPress release

FINEOS Corporation Holdings plc (ASX:FCL), a leading provider of group and individual core systems for life, accident and health insurance, today announced the commencement of trading on the Australian Securities Exchange (ASX) via an initial public offering (IPO). The total number of securities (CHESS Depository Interests or “CDIs”) on offer was 84.4 million at a price of A$2.50 per CDI. Total gross proceeds from the offer amounted to A$211 million. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190816005058/en/ FINEOS lists on the Australian Securities Exchange (Photo: Business Wire) FINEOS intends to use the net proceeds from the IPO to invest further in R&D to grow the FINEOS product footprint and develop new business lines, to invest in additional sales, marketing and client account management capabilities and to pay down existing debt and shareholders selling down. Key areas of growth strategy for FINEOS include: • Inc

European Medicines Agency Validates Marketing Application for Filgotinib for the Treatment of Rheumatoid Arthritis15.8.2019 20:01:00 CESTPress release

Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced that the Marketing Authorization Application (MAA) for filgotinib, an investigational, oral, selective JAK1 inhibitor, for the treatment of adults with rheumatoid arthritis (RA) has been validated and is now under evaluation by the European Medicines Agency (EMA). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190815005605/en/ “We are excited about the validation of this application which is an important milestone in our ongoing work to improve the lives of people living with rheumatoid arthritis and other inflammatory conditions,” said John Sundy, MD, PhD, Senior Vice President, Inflammation and Respiratory Diseases, Gilead Sciences. The MAA for filgotinib is supported by 24-week data from the Phase 3 FINCH clinical trials in which once-daily treatment with filgotinib achieved improvements in clinical signs and symptoms, achievem

Celsius Network Partners With Bitcoin.com15.8.2019 14:55:00 CESTPress release

Celsius Network, the industry-leading cryptocurrency platform, has announced a new partnership with Bitcoin.com, the leading resource for Bitcoin trading, news, and updates. Users of Celsius services are now able to purchase BCH, BTC, ETH, and other mutually supported cryptocurrencies through the Celsius app using Bitcoin.com’s advanced crypto trading platform providing low fees, enhanced accessibility to cryptocurrency, and valuable crypto services. With the shared mission of making financial services fair, rewarding, and transparent, Celsius and Bitcoin.com are well-known in the space for offering inclusive services designed to support the needs and interests of their robust communities. Celsius members can earn interest income of up to 10.53% APR on crypto assets and use their coins as collateral to get dollar loans at rates as low as 4.95% without fees or penalties, no minimums or caps, and no lockups. Bitcoin.com makes it easy to buy dozens of crypto assets instantly and without f

Anesthesia Patient Safety Foundation and Patient Safety Movement Foundation Offer $100,000 Patient Safety Curriculum Award15.8.2019 12:58:00 CESTPress release

The Anesthesia Patient Safety Foundation (APSF), in partnership with the Patient Safety Movement Foundation (PSMF), is now accepting proposals for the Patient Safety Curriculum Award. The $100,000 award will go to an anesthesia education investigator with the intent to modify the PSMF Patient Safety Curriculum to address perioperative patient safety. The awardee will also test the educational efficiency and effectiveness of implementing the curriculum in anesthesia training programs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190815005377/en/ Anesthesia Patient Safety Foundation and Patient Safety Movement Foundation Offer $100,000 Patient Safety Curriculum Award (Graphic: Business Wire) “This important work will add to the considerable value provided by PSMF’s Patient Safety Curriculum,” said Mark Warner, APSF President. “To ensure the safety of patients and achieve our collective goal of zero preventable deaths in hosp